VGLL4 and neoplasm: This was highlighted by Jiao and his team in a study published in 2017 that reported VGLL4 peptide mimics suppress CRC tumour growth by interfering with the transactivation of YAP/TAZ and the β-catenin/TCF4 complex, thereby preventing the constitutive transcription of WNT and Hippo oncogenic target genes.